FibroGen, Inc (FGEN) Social Stream
FIBROGEN INC (FGEN) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering FIBROGEN INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 9 | $30 | $14 | $24.333 | $0.902 | 2597.67% |
| 2021-12-22 | 9 | $29 | $14 | $21.166 | $0.902 | 2246.56% |
| 2022-01-06 | 9 | $29 | $14 | $21 | $0.902 | 2228.16% |
| 2022-01-13 | 8 | $29 | $14 | $19.6 | $0.902 | 2072.95% |
| 2022-03-01 | 7 | $29 | $14 | $19.6 | $0.902 | 2072.95% |
| 2022-03-02 | 7 | $25 | $13 | $16.75 | $0.902 | 1756.98% |
| 2022-05-10 | 6 | $25 | $13 | $16.75 | $0.902 | 1756.98% |
| 2022-05-11 | 6 | $25 | $9 | $14.5 | $0.902 | 1507.54% |
| 2022-05-24 | 5 | $25 | $8 | $13.2 | $0.902 | 1363.41% |
| 2022-08-08 | 7 | $25 | $8 | $13.2 | $0.902 | 1363.41% |
| 2022-10-14 | 7 | $25 | $8 | $14.4 | $0.902 | 1496.45% |
| 2022-11-08 | 7 | $25 | $8 | $15 | $0.902 | 1562.97% |
| 2022-11-09 | 7 | $23 | $9 | $16.4 | $0.902 | 1718.18% |
| 2022-12-15 | 7 | $23 | $9 | $16.2 | $0.902 | 1696.01% |
| 2022-12-20 | 7 | $23 | $9 | $15.8 | $0.902 | 1651.66% |
| 2023-01-05 | 7 | $27 | $9 | $17.6 | $0.902 | 1851.22% |
| 2023-01-22 | 7 | $27 | $9 | $18.6 | $0.902 | 1962.08% |
| 2023-01-26 | 7 | $35 | $9 | $21.333 | $0.902 | 2265.08% |
| 2023-02-08 | 7 | $35 | $9 | $21.333 | $0.902 | 2265.08% |
| 2023-02-23 | 7 | $35 | $14 | $22.5 | $0.902 | 2394.46% |
| 2023-02-27 | 7 | $35 | $15 | $22.666 | $0.902 | 2412.86% |
| 2023-04-25 | 7 | $35 | $16 | $24.333 | $0.902 | 2597.67% |
| 2023-05-01 | 7 | $35 | $16 | $24.833 | $0.902 | 2653.1% |
| 2023-05-10 | 7 | $35 | $16 | $24.666 | $0.902 | 2634.59% |
| 2023-06-02 | 7 | $35 | $16 | $26.166 | $0.902 | 2800.89% |
| 2023-06-06 | 7 | $35 | $16 | $25.5 | $0.902 | 2727.05% |
| 2023-06-27 | 7 | $20 | $3 | $10.8 | $0.902 | 1097.34% |
| 2023-07-19 | 7 | $20 | $2 | $8 | $0.902 | 786.92% |
| 2023-08-07 | 7 | $20 | $2 | $8 | $0.902 | 786.92% |
| 2023-08-08 | 6 | $11 | $2 | $4.375 | $0.902 | 385.03% |
| 2023-11-07 | 5 | $2 | $0.5 | $1.033 | $0.902 | 14.52% |
The Trend in the Analyst Price Target
Over the past 42 months, FGEN's average price target has gone down $58.22.
Over the past 41 weeks, FGEN's average upside potential has been 102.14%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-04-25 | 7 | 35 | 16.0 | 24.333 | 16.390 | 48.46% |
| 2023-06-06 | 7 | 29 | 16.0 | 23.600 | 18.710 | 26.14% |
| 2023-06-27 | 7 | 20 | 2.0 | 8.000 | 2.510 | 218.73% |
| 2023-08-08 | 6 | 11 | 2.0 | 4.375 | 1.440 | 203.82% |
| 2023-11-07 | 4 | 2 | 0.6 | 1.533 | 0.552 | 177.72% |
FGEN Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 3.75 | 0 | 0 | 2 | 1 | 1 | 4 |
The Trend in the Broker Recommendations
FGEN's average broker recommendation rating worsened by 0.46 over the prior 15 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for FGEN as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, FIBROGEN INC's upside potential (average analyst target price relative to current price) is higher than 3508.43% of them.
- FIBROGEN INC's variance in analysts' estimates is lower than -3002.85% of all US stocks.
- In the context of stocks in the mid market cap category, FIBROGEN INC's average analyst price target is greater than 819.47% of them.
- In the context of stocks in the mid market cap category, FIBROGEN INC's number of analysts covering the stock is greater than 1504.7% of them.
In the Pharmaceutical Products industry, TARO, ITCI, and IRWD are the three stocks most similar to FIBROGEN INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is FGEN a Buy, Hold or Sell? See the POWR Ratings now!